Comparison of clinicopathological characteristics and survival outcomes between gallbladder mucinous adenocarcinoma and gallbladder adenocarcinoma: A propensity score-matched study

doi:10.4251/wjgo.v15.i8.1436

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2455)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

1035

Figures (1-3)

148

Tables (1-3)

151

Sum=1413

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

160

Download

527

Sum=687

Publishing Process of This Article

Item

Count

Browse

Download

193

Sum=284

Aug 15, 2023 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1436-1450
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1436

Full Size Figure Download Figure

Figure 2 Survival analysis of gallbladder mucinous adenocarcinoma and typical gallbladder adenocarcinoma patients. A: Overall survival (OS) for patients with gallbladder mucinous adenocarcinoma (GBMAC) and typical gallbladder adenocarcinoma (GBAC) in the unmatched cohort; B: Cancer-speciﬁc survival (CSS) for patients with GBMAC and typical GBAC in the unmatched cohort; C: OS for patients with GBMAC and typical GBAC in the propensity score matching (PSM) cohort; D: CSS for patients with GBMAC and typical GBAC in the PSM cohort. GBMAC: Gallbladder mucinous adenocarcinoma; GBAC: Gallbladder adenocarcinoma.

Citation: Yang WW, Fang YT, Niu YR, Sun YK. Comparison of clinicopathological characteristics and survival outcomes between gallbladder mucinous adenocarcinoma and gallbladder adenocarcinoma: A propensity score-matched study. World J Gastrointest Oncol 2023; 15(8): 1436-1450
URL: https://www.wjgnet.com/1948-5204/full/v15/i8/1436.htm
DOI: https://dx.doi.org/10.4251/wjgo.v15.i8.1436